Philips rearranges field organization
Philips Medical Systems North America of Shelton, CT, plans to restructure its field sales organization, the company announced last month. The firm will create four operating units that will be located in New York, Los Angeles, Chicago, and Atlanta. The
Philips Medical Systems North America of Shelton, CT, plans to restructure its field sales organization, the company announced last month. The firm will create four operating units that will be located in New York, Los Angeles, Chicago, and Atlanta. The four-unit structure will replace the company's previous two-zone sales configuration. Each regional operating unit will function under a regional vice president, and the regional bases' activities will be coordinated with headquarters vice presidents, according to the company. Philips plans to increase its North American sales force by 20%.
The company is making the change to accommodate a more diverse client base, according to Jack Price, president and CEO. Philips hopes the new structure will allow it to respond more quickly and with more flexibility to its customers, which include independent hospitals, national and regional affiliations, HMOs, buying groups, and freestanding imaging centers.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
